Comparison of multiple chronic obstructive pulmonary disease (COPD) indices in Chinese COPD patients

dc.contributor.authorZhang, Jinsong
dc.contributor.authorMiller, Anastasia
dc.contributor.authorLi, Yongxia
dc.contributor.authorLan, Qinqin
dc.contributor.authorZhang, Ning
dc.contributor.authorChai, Yanling
dc.contributor.authorHai, Bing
dc.creator.orcidhttps://orcid.org/0000-0001-5928-4026
dc.date.accessioned2019-10-29T15:18:30Z
dc.date.available2019-10-29T15:18:30Z
dc.date.issued2018-04
dc.description.abstractBackground: Chronic obstructive pulmonary disease (COPD) is a serious chronic condition with a global impact. Symptoms of COPD include progressive dyspnea, breathlessness, cough, and sputum production, which have a considerable impact on the lives of patients. In addition to the human cost of living with COPD and the resulting death, COPD entails a huge economic burden on the Chinese population, with patients spending up to one-third of the average family income on COPD management in some regions is clinically beneficial to adopt preventable measures via prudent COPD care utilization, monetary costs, and hospitalizations. Methods: Toward this end, this study compared the relative effectiveness of six indices in predicting patient healthcare utilization, cost of care, and patient health outcome. The six assessment systems evaluated included the three multidimensional Body mass index, Obstruction, Dyspnea, Exercise capacity index, Dyspnea, Obstruction, Smoking, Exacerbation (DOSE) index, and COPD Assessment Test index, or the unidimensional measures that best predict the future of patient healthcare utilization, cost of care, and patient health outcome among Chinese COPD patients. Results: Multiple linear regression models were created for each healthcare utilization, cost, and outcome including a single COPD index and the same group of demographic variables for each of the outcomes. Conclusion: We conclude that the DOSE index facilitates the prediction of patient healthcare utilization, disease expenditure, and negative clinical outcomes. Our study indicates that the DOSE index has a potential role beyond clinical predictions.en_US
dc.identifier.citationThis is the published version of an article that is available at https://doi.org/10.4046/trd.2017.0082. Recommended citation: Zhang, J., Miller, A., Li, Y., Lan, Q., Zhang, N., Chai, Y., & Hai, B. (2018). Comparison of multiple chronic obstructive pulmonary disease (COPD) indices in Chinese COPD patients. Tuberculosis and Respiratory Diseases, 81(2), 116. This item has been deposited in accordance with publisher copyright and licensing terms and with the author’s permission.en_US
dc.identifier.urihttps://doi.org/10.4046/trd.2017.0082
dc.identifier.urihttps://hdl.handle.net/11274/11923
dc.language.isoen_USen_US
dc.publisherThe Korean Academy of Tuberculosis and Respiratory Diseasesen_US
dc.rights.licenseCC-BY-NC
dc.subjectBody mass indexen_US
dc.subjectAsian continental ancestryen_US
dc.subjectCosts and cost analysisen_US
dc.subjectCoughen_US
dc.subjectDelivery of healthcareen_US
dc.subjectDyspneaen_US
dc.subjectHealth expendituresen_US
dc.subjectHospitalizationen_US
dc.subjectPulmonary diseaseen_US
dc.subjectLinear modelsen_US
dc.subjectChronic obstructiveen_US
dc.subjectRespiratory function testsen_US
dc.subjectSmokeen_US
dc.subjectSmokingen_US
dc.subjectSputumen_US
dc.subjectPulmonary function testen_US
dc.titleComparison of multiple chronic obstructive pulmonary disease (COPD) indices in Chinese COPD patientsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Miller-Comparison Multiple Chronic.pdf
Size:
166.11 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.68 KB
Format:
Item-specific license agreed upon to submission
Description: